Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Oct 27, 2014 at 8:40 AM EDT

Merck Earnings Look Very Mixed in Major Restructuring

Merck reported better-than-expected third-quarter earnings Monday morning.

Chris Lange | Oct 24, 2014 at 10:15 AM EDT

Lakeland Private Placement Comes at Severe Discount to Ebola Trade

Lakeland Industries announced that it entered into a definitive securities purchase agreement to raise $11.2 million in a private placement…

Jon C. Ogg | Oct 24, 2014 at 8:05 AM EDT

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

Pfizer's new buyback is simply too large and too significant to ignore, and it might jokingly be called "on Viagra."

Jon C. Ogg | Oct 23, 2014 at 3:30 PM EDT

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

ThinkstockJust when you thought the Ebola virus outbreak risk was dwindling down… Fresh headlines from Dow Jones and the New…

Chris Lange | Oct 23, 2014 at 2:39 PM EDT

Will Celgene Become the Next $100 Billion Biotech Stock?

ThinkstockDoes Celgene Corporation (NASDAQ: CELG) have what it takes to make it to a $100 billion market cap? Some analysts…

Lee Jackson | Oct 23, 2014 at 9:15 AM EDT

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

The following companies were featured in a new Leerink report on understand testing trends for sexually transmitted diseases.

Chris Lange | Oct 22, 2014 at 11:50 AM EDT

After Multiyear Turnaround, Is Boston Scientific Finally (and Really) Back?

24/7 Wall St. would ask if this turnaround in Boston Scientific earnings and outlook is really convincing investors.

Lee Jackson | Oct 22, 2014 at 10:05 AM EDT

3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion

A new research report from Merrill Lynch features three top pharmaceutical companies, dubbed the “Irish 3-Pack.”

Chris Lange | Oct 22, 2014 at 9:05 AM EDT

Biogen Takes Breather on Earnings and MS Drug Sales

Biogen Idec reported better-than-expected third-quarter results before the market opened Wednesday.

Jon C. Ogg | Oct 21, 2014 at 4:22 PM EDT

The Plan to Drive Amgen Shares Up Over 70%

Jon OggAmgen Inc. (NASDAQ: AMGN) used to be the king of biotech by size. That was then, and now is…

Chris Lange | Oct 21, 2014 at 3:08 PM EDT

Why Everyone Likes Illumina Again

ThinkstockIllumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday as $0.77 in earnings per share and $481…

Chris Lange | Oct 21, 2014 at 9:45 AM EDT

Connecture Files for IPO: Health Care Insurance Platform

Connecture Inc. has filed with the Securities and Exchange Commission to have an initial public offering.

Jon C. Ogg | Oct 20, 2014 at 1:30 PM EDT

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

Goldman Sachs has initiated on MannKind with a Neutral rating and a $6 price target, a move that may seem…

Jon C. Ogg | Oct 20, 2014 at 10:45 AM EDT

Ebola Stock Fallout Severe on Monday

Some of the Ebola high-flying stocks saw their share prices crater on Monday as Ebola fears are subsiding for several…

Chris Lange | Oct 20, 2014 at 10:24 AM EDT

NewLink Scores Major Partners With Roche’s Genentech

NewLink Genetics announced that it has entered into an exclusive worldwide license agreement with Genentech for the development of NewLink's…

1 … 277 278 279 280 281 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Merck Earnings Look Very Mixed in Major Restructuring

Lakeland Private Placement Comes at Severe Discount to Ebola Trade

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Will Celgene Become the Next $100 Billion Biotech Stock?

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

After Multiyear Turnaround, Is Boston Scientific Finally (and Really) Back?

3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion

Biogen Takes Breather on Earnings and MS Drug Sales

The Plan to Drive Amgen Shares Up Over 70%

Why Everyone Likes Illumina Again

Connecture Files for IPO: Health Care Insurance Platform

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

Ebola Stock Fallout Severe on Monday

NewLink Scores Major Partners With Roche’s Genentech

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Burry Isn’t Alone in Loading Up on PayPal — Here’s Why It’s Time to Follow the Smart Money

Think You Can’t Get Paid From Social Security Before 62? Here’s a Scenario Where You Could Start Getting Checks in Your 40s

Analysts See 10% Upside for Alphabet Following Q1 Earnings

Think You Can't Get Paid From Social Security Before 62? Here's a Scenario Where You Could Start Getting Checks in Your 40s

Nvidia's Stock Plunged 90% Twice Before Becoming Most Valuable Company

Burry Isn’t Alone in Loading Up on PayPal — Here’s Why It’s Time to Follow the Smart Money

Think You Can’t Get Paid From Social Security Before 62? Here’s a Scenario Where You Could Start Getting Checks in Your 40s

Health and Healthcare Articles

All Health and Healthcare Articles

Merck Earnings Look Very Mixed in Major Restructuring

Lakeland Private Placement Comes at Severe Discount to Ebola Trade

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Will Celgene Become the Next $100 Billion Biotech Stock?

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

After Multiyear Turnaround, Is Boston Scientific Finally (and Really) Back?

3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion

Biogen Takes Breather on Earnings and MS Drug Sales

The Plan to Drive Amgen Shares Up Over 70%

Why Everyone Likes Illumina Again

Connecture Files for IPO: Health Care Insurance Platform

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

Ebola Stock Fallout Severe on Monday

NewLink Scores Major Partners With Roche’s Genentech

Stock Market Live May 4, 2026: S&P 500 (SPY) Sinks on Iran Uncertainty Again

Live Nasdaq Composite: Tech Holds Its Ground as M&A and AI Boom Drown Out Oil Noise

Burry Isn’t Alone in Loading Up on PayPal — Here’s Why It’s Time to Follow the Smart Money

Think You Can’t Get Paid From Social Security Before 62? Here’s a Scenario Where You Could Start Getting Checks in Your 40s

Analysts See 10% Upside for Alphabet Following Q1 Earnings

Featured Reads

Think You Can't Get Paid From Social Security Before 62? Here's a Scenario Where You Could Start Getting Checks in Your 40s

Nvidia's Stock Plunged 90% Twice Before Becoming Most Valuable Company